Codexis, Inc. (CDXS)
1.92
+0.09
(+4.92%)
USD |
NASDAQ |
Dec 08, 16:00
1.925
0.00 (0.00%)
Pre-Market: 20:00
Codexis Total Liabilities (Quarterly): 85.42M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| EyePoint Pharmaceuticals, Inc. | 51.51M |
| Tarsus Pharmaceuticals, Inc. | 199.48M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 123.96M |
| Shareholders Equity (Quarterly) | 38.54M |
| Debt to Equity Ratio | 1.780 |
| Current Ratio | 4.124 |
| Net Debt Paydown Yield | -2.37% |